{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:57:12Z","timestamp":1794952632049,"version":"4.9.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002611","name":"University of Seoul","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002611","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004462","name":"National Research Council","doi-asserted-by":"publisher","award":["SAC.AD002.173.058"],"award-info":[{"award-number":["SAC.AD002.173.058"]}],"id":[{"id":"10.13039\/501100004462","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neurot.2025.e00793","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T22:04:33Z","timestamp":1763417073000},"page":"e00793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Validation in Drosophila of the in silico predicted clomipramine as repurposable for SOD1-ALS"],"prefix":"10.1016","volume":"23","author":[{"given":"Francesco","family":"Liguori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Amadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Angioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Ferriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iolanda","family":"Passaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiammetta","family":"Vern\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Volont\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2025.e00793_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41576-023-00592-y","article-title":"Amyotrophic lateral sclerosis: translating genetic discoveries into therapies","author":"Ak\u00e7imen","year":"2023","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.neurot.2025.e00793_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","author":"Masrori","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurot.2025.e00793_bib3","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.neurot.2025.e00793_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12408","article-title":"Projected increase in amyotrophic lateral sclerosis from 2015 to 2040","volume":"7","author":"Arthur","year":"2016","journal-title":"Nat Commun"},{"issue":"3-4","key":"10.1016\/j.neurot.2025.e00793_bib5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/21678421.2024.2447919","article-title":"Amyotrophic lateral sclerosis estimated prevalence cases from 2022 to 2030, data from the national ALS registry","volume":"26","author":"Mehta","year":"2025","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00793_bib6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole study group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurot.2025.e00793_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/DDDT.S123776","article-title":"Riluzole 5 mg\/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis","volume":"11","author":"Dyer","year":"2017","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00793_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/cpdd.1168","article-title":"Pharmacokinetics, bioavailability, and swallowing safety with riluzole oral film","volume":"12","author":"Wymer","year":"2023","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00793_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-, placebo-controlled trial","volume":"16","author":"Group","year":"2017","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00793_bib10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00793_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3934\/Neuroscience.2024010","article-title":"Assessing the efficacy of amyotrophic lateral sclerosis drugs in slowing disease progression: a literature review","volume":"11","author":"Ansari","year":"2024","journal-title":"AIMS Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00793_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00793_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00415-025-12975-8","article-title":"Advancements in genetic research and RNA therapy strategies for amyotrophic lateral sclerosis (ALS): current progress and future prospects","volume":"272","author":"Ruffo","year":"2025","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00793_bib14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12859-021-04076-w","article-title":"SAveRUNNER: an R-based tool for drug repurposing","volume":"22","author":"Fiscon","year":"2021","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.neurot.2025.e00793_bib15","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-021-01064-z","article-title":"Drug repurposing: a network-based approach to amyotrophic lateral sclerosis","author":"Fiscon","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2025.e00793_bib16","series-title":"Clomipramine","author":"Wilson","year":"2024"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00793_bib17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0707253","article-title":"Tricyclic antidepressant pharmacology and therapeutic drug interactions updated","volume":"151","author":"Gillman","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00793_bib18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0022-3565(24)29415-5","article-title":"S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine","volume":"298","author":"Millan","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00793_bib19","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/s41467-017-02119-6","article-title":"Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic","volume":"8","author":"Faissner","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00793_bib20","first-page":"28","article-title":"The anti-inflammatory effects of antidepressants on colitis","volume":"17","author":"Khazraei","year":"2024","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00793_bib21","first-page":"1728","article-title":"Amyotrophic lateral sclerosis disease burden: doing better at getting better","volume":"18","author":"Volont\u00e9","year":"2023","journal-title":"Neural Regen Res"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00793_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167192","article-title":"Pan-neuronal expression of human mutant SOD1 in Drosophila impairs survival and motor performance, induces early neuroinflammation and chromosome aberrations","volume":"1870","author":"Liguori","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.neurot.2025.e00793_bib23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00793_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.neurot.2025.e00793_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31033","article-title":"A gene-nutrient interaction between vitamin B6 and serine hydroxymethyltransferase (SHMT) affects genome integrity in Drosophila","author":"Pilesi","year":"2023","journal-title":"J Cell Physiol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00793_bib26","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1365-2583.2010.01036.x","article-title":"Functional analysis and molecular characterization of two acetylcholinesterases from the German cockroach, Blattella germanica","volume":"19","author":"Kim","year":"2010","journal-title":"Insect Mol Biol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00793_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cub.2005.12.011","article-title":"The class I PITP giotto is required for Drosophila cytokinesis","volume":"16","author":"Giansanti","year":"2006","journal-title":"Curr Biol"},{"key":"10.1016\/j.neurot.2025.e00793_bib28","series-title":"Fructose-2,6-bisphosphate restores TDP-43 pathology-driven genome repair deficiency in motor neuron diseases","author":"Chakraborty","year":"2025"},{"issue":"30","key":"10.1016\/j.neurot.2025.e00793_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm6376","article-title":"A quantitative biology approach correlates neuronal toxicity with the largest inclusions of TDP-43","volume":"8","author":"Cascella","year":"2022","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00793_bib30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/NRR.NRR-D-24-00034","article-title":"Empowering the NSC-34 cell line as a motor neuron model: cytosine arabinoside's action","volume":"21","author":"Vitale","year":"2025","journal-title":"Neural Regen Res"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00793_bib31","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/mp.2011.26","article-title":"Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor","volume":"16","author":"Anacker","year":"2011","journal-title":"Mol Psychiatr"},{"issue":"35","key":"10.1016\/j.neurot.2025.e00793_bib32","doi-asserted-by":"crossref","first-page":"56147","DOI":"10.18632\/oncotarget.11269","article-title":"Oasis 2: online application for survival analysis 2 with features for the analysis of maximal lifespan and healthspan in aging research","volume":"7","author":"Han","year":"2016","journal-title":"Oncotarget"},{"issue":"W1","key":"10.1016\/j.neurot.2025.e00793_bib33","doi-asserted-by":"crossref","first-page":"W356","DOI":"10.1093\/nar\/gkx374","article-title":"PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issue","key":"10.1016\/j.neurot.2025.e00793_bib34","doi-asserted-by":"crossref","first-page":"W609","DOI":"10.1093\/nar\/gkq300","article-title":"PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach","volume":"38","author":"Liu","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00793_bib35","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.tins.2024.09.001","article-title":"Emerging roles of antimicrobial peptides in innate immunity, neuronal function, and neurodegeneration","volume":"47","author":"Lee","year":"2024","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neurot.2025.e00793_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000086648","article-title":"Antimicrobial peptides in Drosophila: structures, activities and gene regulation","volume":"86","author":"Imler","year":"2005","journal-title":"Chem Immunol Allergy"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00793_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/aja.1001940306","article-title":"Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons","volume":"194","author":"Cashman","year":"1992","journal-title":"Dev Dyn"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00793_bib38","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1007\/s10571-023-01423-8","article-title":"In vitro models of amyotrophic lateral sclerosis","volume":"43","author":"Zhou","year":"2023","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00793_bib39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41419-024-06787-3","article-title":"Vitamin B6 deficiency cooperates with oncogenic Ras to induce malignant tumors in Drosophila","volume":"15","author":"Pilesi","year":"2024","journal-title":"Cell Death Dis"},{"issue":"23","key":"10.1016\/j.neurot.2025.e00793_bib40","article-title":"Neuronal progenitors suffer genotoxic stress in the drosophila clock mutant per 0","volume":"13","author":"Colonna","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.neurot.2025.e00793_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-1-61779-998-3_9","article-title":"Analysis of DNA damage and repair in nuclear and mitochondrial DNA of animal cells using quantitative PCR","volume":"920","author":"Furda","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"690","key":"10.1016\/j.neurot.2025.e00793_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/pgmj.59.690.229","article-title":"Efficacy and side effects of mianserin, a tetracyclic antidepressant","volume":"59","author":"Wakeling","year":"1983","journal-title":"Postgrad Med J"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00793_bib43","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0022-3565(25)12943-1","article-title":"Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan","volume":"277","author":"de Boer","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00793_bib44","article-title":"Pharmacology of aging: Drosophila as a tool to validate drug targets for healthy lifespan","volume":"2","author":"Dos Santos","year":"2024","journal-title":"Aging Biol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00793_bib45","first-page":"188","article-title":"Modafinil for excessive sleepiness associated with chronic shift work sleep disorder: effects on patient functioning and health-related quality of life","volume":"9","author":"Erman","year":"2007","journal-title":"Prim Care Companion J Clin Psychiatr"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00793_bib46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3940(03)00006-5","article-title":"Modafinil increases histamine release in the anterior hypothalamus of rats","volume":"339","author":"Ishizuka","year":"2003","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00793_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neulet.2010.08.005","article-title":"Modanifil activates the histaminergic system through the orexinergic neurons","volume":"483","author":"Ishizuka","year":"2010","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00793_bib48","first-page":"349","article-title":"Mechanisms of modafinil: a review of current research","volume":"3","author":"Gerrard","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.neurot.2025.e00793_bib49","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuropharm.2017.06.016","article-title":"Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons","volume":"123","author":"Avelar","year":"2017","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00793_bib50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41582-024-01049-4","article-title":"Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis","volume":"21","author":"Faller","year":"2025","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00793_bib51","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J Cell Biol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00793_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","article-title":"ALS: a disease of motor neurons and their nonneuronal neighbors","volume":"52","author":"Boill\u00e9e","year":"2006","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00793_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052400","article-title":"Comprehensive research on past and future therapeutic strategies devoted to treatment of amyotrophic lateral sclerosis","volume":"23","author":"Sever","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00793_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/cells12111523","article-title":"Current State and future directions in the therapy of ALS","volume":"12","author":"Tzeplaeff","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00793_bib55","doi-asserted-by":"crossref","first-page":"fcaf184","DOI":"10.1093\/braincomms\/fcaf184","article-title":"Drug repurposing candidates for amyotrophic lateral sclerosis using common and rare genetic variants","volume":"7","author":"Gerring","year":"2025","journal-title":"Brain Commun"},{"key":"10.1016\/j.neurot.2025.e00793_bib56","first-page":"1","article-title":"Investigating the impact of SOD1 mutations on amyotrophic lateral sclerosis progression and potential drug repurposing through","author":"Alzahrani","year":"2024","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00793_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210752","article-title":"Chemotherapeutic agent 5-fluorouracil increases survival of SOD1 mouse model of ALS","volume":"14","author":"Rando","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00793_bib58","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/17460441.2025.2474661","article-title":"Drug repurposing in amyotrophic lateral sclerosis (ALS)","volume":"20","author":"Carroll","year":"2025","journal-title":"Expet Opin Drug Discov"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00793_bib59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00210-011-0704-0","article-title":"Interactions of recombinant human histamine H1R, H2R, H3R, and H4R receptors with 34 antidepressants and antipsychotics","volume":"385","author":"Appl","year":"2012","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00793_bib60","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-3565(25)21446-X","article-title":"Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro","volume":"230","author":"Richelson","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00793_bib61","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jpain.2006.10.001","article-title":"Sodium channel blockade may contribute to the analgesic efficacy of antidepressants","volume":"8","author":"Dick","year":"2007","journal-title":"J Pain"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00793_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11112967","article-title":"Characteristics of sensory neuron dysfunction in Amyotrophic Lateral Sclerosis (ALS): potential for ALS therapy","volume":"11","author":"Seki","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.neurot.2025.e00793_bib63","doi-asserted-by":"crossref","DOI":"10.32440\/ar.2022.139.01.rev06","article-title":"Amyotrophic lateral sclerosis is not only a motor neuron disease: impact of the sympathoadrenal axis","author":"Fernandez","year":"2022","journal-title":"An RANM"},{"issue":"44","key":"10.1016\/j.neurot.2025.e00793_bib64","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1523\/JNEUROSCI.1214-19.2019","article-title":"Circuit-Specific early impairment of proprioceptive sensory neurons in the SOD1","volume":"39","author":"Seki","year":"2019","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00793_bib65","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/14756360701809977","article-title":"Comparative study of the inhibitory effect of antidepressants on cholinesterase activity in Bungarus sindanus (krait) venom, human serum and rat striatum","volume":"23","author":"Ahmed","year":"2008","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00793_bib66","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1248\/bpb.b23-00719","article-title":"Inhibitory actions of antidepressants, hypnotics, and anxiolytics on recombinant human acetylcholinesterase activity","volume":"47","author":"Obara","year":"2024","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.neurot.2025.e00793_bib67","series-title":"StatPearls","article-title":"Cholinergic crisis","author":"Adeyinka","year":"2025"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00793_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020221","article-title":"TDP-43 regulation of AChE expression can mediate ALS-like phenotype in zebrafish","volume":"10","author":"Campanari","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neurot.2025.e00793_bib69","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fnmol.2016.00160","article-title":"Neuromuscular junction impairment in amyotrophic lateral sclerosis: reassessing the role of acetylcholinesterase","volume":"9","author":"Campanari","year":"2016","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00793_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25051086","article-title":"Mutations in superoxide dismutase 1 (Sod1) linked to familial amyotrophic lateral sclerosis can disrupt high-affinity zinc-binding promoted by the copper chaperone for Sod1 (Ccs)","volume":"25","author":"Boyd","year":"2020","journal-title":"Molecules"},{"issue":"23","key":"10.1016\/j.neurot.2025.e00793_bib71","doi-asserted-by":"crossref","first-page":"16169","DOI":"10.1074\/jbc.M801522200","article-title":"Structures of the G85R variant of SOD1 in familial amyotrophic lateral sclerosis","volume":"283","author":"Cao","year":"2008","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00793_bib72","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0022-2836(02)01090-2","article-title":"Insights into Lou Gehrig's disease from the structure and instability of the A4V mutant of human Cu,Zn superoxide dismutase","volume":"324","author":"Cardoso","year":"2002","journal-title":"J Mol Biol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00793_bib73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(24)00479-4","article-title":"Amyotrophic lateral sclerosis caused by SOD1 variants: from genetic discovery to disease prevention","volume":"24","author":"Benatar","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurot.2025.e00793_bib74","doi-asserted-by":"crossref","DOI":"10.1155\/humu\/9792233","article-title":"Phenotypic characterization of ALS-causing SOD1 mutations affecting polypeptide length","volume":"2025","author":"Berdy\u0144ski","year":"2025","journal-title":"Hum Mutat"},{"key":"10.1016\/j.neurot.2025.e00793_bib75","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/B978-0-444-64076-5.00039-9","article-title":"Emerging understanding of the genotype-phenotype relationship in amyotrophic lateral sclerosis","volume":"148","author":"Goutman","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00793_bib76","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2174\/1871527314666150225143921","article-title":"New kid on the block: does histamine get along with inflammation in amyotrophic lateral sclerosis?","volume":"14","author":"Volont\u00e9","year":"2015","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00793_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083854","article-title":"Neuroinflammation and amyotrophic lateral sclerosis: recent advances in anti-inflammatory cytokines as therapeutic strategies","volume":"26","author":"Stacchiotti","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00793_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115329","article-title":"Predicting amyotrophic lateral sclerosis in the pre-symptomatic phase: insights from SOD1G93A mouse gene expression profiles","volume":"392","author":"La Cognata","year":"2025","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurot.2025.e00793_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.615695","article-title":"The anti-inflammatory effect of the tricyclic antidepressant clomipramine and its high penetration in the brain might be useful to prevent the psychiatric consequences of SARS-CoV-2 infection","volume":"12","author":"Nobile","year":"2021","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00793_bib80","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0891-5849(00)00349-X","article-title":"Increased oxidative damage to DNA in ALS patients","volume":"29","author":"Bogdanov","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.neurot.2025.e00793_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2019.102669","article-title":"DNA repair and neurological disease: from molecular understanding to the development of diagnostics and model organisms","volume":"81","author":"Abugable","year":"2019","journal-title":"DNA Repair (Amst)"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00793_bib82","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40478-019-0874-4","article-title":"DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons and DNA repair is activatable in iPSC-derived motor neurons with SOD1 mutations","volume":"8","author":"Kim","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neurot.2025.e00793_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.786420","article-title":"DNA damage, defective DNA repair, and neurodegeneration in amyotrophic lateral sclerosis","volume":"14","author":"Konopka","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00793_bib84","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0022-3565(24)37161-7","article-title":"Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites","volume":"283","author":"Owens","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"24","key":"10.1016\/j.neurot.2025.e00793_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413446","article-title":"Targeting 5-HT is a potential therapeutic strategy for neurodegenerative diseases","volume":"25","author":"Xing","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00793_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100071","article-title":"Targeting the serotonergic system in the treatment of neurodegenerative diseases-emerging therapies and unmet challenges","volume":"77","author":"Br\u00fcge","year":"2025","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00793_bib87","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s10571-023-01320-0","article-title":"The serotonergic system and amyotrophic lateral sclerosis: a review of current evidence","volume":"43","author":"Yang","year":"2023","journal-title":"Cell Mol Neurobiol"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00793_bib88","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1177\/0269881119874461","article-title":"Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression","volume":"33","author":"Ahmadimanesh","year":"2019","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00793_bib89","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2165\/00003495-199039010-00010","article-title":"Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder","volume":"39","author":"McTavish","year":"1990","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00793_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22083977","article-title":"Where and why modeling amyotrophic lateral sclerosis","volume":"22","author":"Liguori","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:07:31Z","timestamp":1774858051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925002715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1878747925002715"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00793","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation in Drosophila of the in silico predicted clomipramine as repurposable for SOD1-ALS","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00793"}}